Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 1.94 and has seen 0.41 million shares traded in the recent trading session. The PTPI stock price is -467.5% off its 52-week high price of $2.27 and 45.0% above the 52-week low of $0.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.2 million shares traded. The 3-month trading volume is 1.68 million shares.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Sporting 2.20% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PTPI stock price touched $0.40 or saw a rise of 15.79%. Year-to-date, Petros Pharmaceuticals Inc shares have moved 2.61%, while the 5-day performance has seen it change 15.19%. Over the past 30 days, the shares of Petros Pharmaceuticals Inc (NASDAQ:PTPI) have changed 19.73%. Short interest in the company has seen 0.2 million shares shorted with days to cover at 0.72.

Petros Pharmaceuticals Inc (PTPI) estimates and forecasts

The company’s shares have lost -1.29% over the past 6 months.

PTPI Dividends

Petros Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Insiders own 8.10% of the company shares, while shares held by institutions stand at 2.29% with a share float percentage of 2.49%. Investors are also buoyed by the number of investors in a company, with Petros Pharmaceuticals Inc having a total of 13.0 institutions that hold shares in the company.